Swiss Life Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.5M | Buy |
58,936
+26,234
| +80% | +$5.44M | 0.05% | 288 |
|
|
2026
Q1 | $7.34M | Buy |
32,702
+5,100
| +18% | +$1.27M | 0.04% | 338 |
|
|
2025
Q4 | $6.65M | Sell |
27,602
-14,421
| -34% | -$3.69M | 0.03% | 356 |
|
|
2025
Q3 | $11.5M | Buy |
42,023
+3,987
| +10% | +$1.09M | 0.06% | 245 |
|
|
2025
Q2 | $9.81M | Buy |
38,036
+24,408
| +179% | +$5.82M | 0.06% | 239 |
|
|
2025
Q1 | $3.05M | Sell |
13,628
-5,784
| -30% | -$1.35M | 0.02% | 424 |
|
|
2024
Q4 | $4.44M | Buy |
19,412
+4,331
| +29% | +$1.04M | 0.03% | 330 |
|
|
2024
Q3 | $3.68M | Sell |
15,081
-4,261
| -22% | -$952K | 0.04% | 293 |
|
|
2024
Q2 | $3.7M | Buy |
19,342
+5,481
| +40% | +$1.11M | 0.04% | 296 |
|
|
2024
Q1 | $2.74M | Sell |
13,861
-53,542
| -79% | -$9.81M | 0.04% | 300 |
|
|
2023
Q4 | $11.6M | Buy |
67,403
+55,761
| +479% | +$8.57M | 0.14% | 168 |
|
|
2023
Q3 | $1.72M | Sell |
11,642
-31
| -0.3% | -$5.61K | 0.03% | 507 |
|
|
2023
Q2 | $2.55M | Sell |
11,673
-5,580
| -32% | -$1.24M | 0.04% | 444 |
|
|
2023
Q1 | $3.78M | Buy |
17,253
+665
| +4% | +$144K | 0.06% | 374 |
|
|
2022
Q4 | $3.46M | Sell |
16,588
-2,030
| -11% | -$446K | 0.06% | 344 |
|
|
2022
Q3 | $4.06M | Sell |
18,618
-2,644
| -12% | -$602K | 0.07% | 296 |
|
|
2022
Q2 | $4.46M | Sell |
21,262
-1,679
| -7% | -$357K | 0.07% | 295 |
|
|
2022
Q1 | $5.56M | Sell |
22,941
-2,039
| -8% | -$493K | 0.08% | 272 |
|
|
2021
Q4 | $6.51M | Sell |
24,980
-4,121
| -14% | -$1.07M | 0.08% | 267 |
|
|
2021
Q3 | $7.67M | Buy |
29,101
+4,362
| +18% | +$1.19M | 0.11% | 222 |
|
|
2021
Q2 | $7.96M | Sell |
24,739
-6,738
| -21% | -$1.42M | 0.08% | 236 |
|
|
2021
Q1 | $6.11M | Sell |
31,477
-3,828
| -11% | -$768K | 0.09% | 264 |
|
|
2020
Q4 | $7.5M | Buy |
+35,305
| New | +$7.04M | 0.11% | 218 |
|
|
2020
Q3 | – | Sell |
-2,066
| Closed | -$397K | – | 515 |
|
|
2020
Q2 | $397K | Sell |
2,066
-2,758
| -57% | -$451K | 0.01% | 450 |
|
|
2020
Q1 | $710K | Buy |
+4,824
| New | +$768K | 0.01% | 397 |
|
|
2019
Q4 | – | Sell |
-9,155
| Closed | -$1.24M | – | 525 |
|
|
2019
Q3 | $1.24M | Buy |
9,155
+5,684
| +164% | +$745K | 0.02% | 387 |
|
|
2019
Q2 | $423K | Buy |
+3,471
| New | +$384K | 0.01% | 478 |
|
|
2018
Q4 | – | Sell |
-27,989
| Closed | -$3.23M | – | 407 |
|
|
2018
Q3 | $3.23M | Buy |
27,989
+468
| +2% | +$51.3K | 0.04% | 240 |
|
|
2018
Q2 | $2.85M | Buy |
27,521
+6,788
| +33% | +$687K | 0.04% | 236 |
|
|
2018
Q1 | $2.04M | Buy |
20,733
+2,443
| +13% | +$231K | 0.04% | 293 |
|
|
2017
Q4 | $1.55M | Buy |
18,290
+11,884
| +186% | +$982K | 0.03% | 260 |
|
|
2017
Q3 | $493K | Sell |
6,406
-11,608
| -64% | -$888K | 0.01% | 373 |
|
|
2017
Q2 | $1.4M | Buy |
18,014
+6,694
| +59% | +$479K | 0.04% | 241 |
|
|
2017
Q1 | $816K | Buy |
11,320
+6,420
| +131% | +$444K | 0.02% | 338 |
|
|
2016
Q4 | $304K | Buy |
+4,900
| New | +$300K | 0.01% | 407 |
|
|
2016
Q2 | – | Sell |
-30,157
| Closed | -$1.74M | – | 375 |
|
|
2016
Q1 | $1.74M | Buy |
+30,157
| New | +$1.71M | 0.07% | 140 |
|
Other funds holding RMD
Swiss Life Asset Management's RMD Position: Q2 2026 in Review
Swiss Life Asset Management increased its ResMed (RMD) stake by 80% in Q2 2026, buying an estimated $5.44M and bringing the position to 58,936 shares worth $11.5M. The position accounts for 0.05% of the portfolio, ranked #288.
Swiss Life Asset Management first reported a position in RMD in Q1 2016 and has held it in 36 quarters since. The position peaked at $11.6M in Q4 2023. 599 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Swiss Life Asset Management held 58,936 shares of ResMed worth $11.5M as of Q2 2026.
- Swiss Life Asset Management bought 26,234 ResMed shares in Q2 2026, an estimated $5.44M.
- ResMed made up 0.05% of Swiss Life Asset Management's portfolio in Q2 2026, its #288 holding.
- Swiss Life Asset Management first reported a position in ResMed in Q1 2016 and has held it in 36 quarters since.
- Swiss Life Asset Management's ResMed position peaked at $11.6M in Q4 2023.
- 599 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.